MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617097536 A) filed by Haisco Pharmaceutical Group Co. , Ltd. on August 12, 2026, for Pharmaceutical Composition Comprising Braf Inhibitor And Use Of Pharmaceutical Composition In Medicine.
Inventors include Jiang, Wei; and Wang, Li.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to a pharmaceutical composition or a pharmaceutical preparation. The pharmaceutical composition or the pharmaceutical preparation comprises a therapeutically effective amount of an active ingredient M and a pharmaceutically acceptable excipient, wherein the active ingredient M is selected from a compound as shown in general formula I or a stereoisomer, tautomer, deuterated product, solvate, prodrug, metabolite, pharmaceutically acceptable salt or eutectic crystal thereof, and the pharmaceutical composition or the pharmaceutical preparation comprises 1-1000 mg of the active ingredient M. The present invention also relates to a use of the pharmaceutical composition or the pharmaceutical preparation in preparation of a related drug for treating cancers.
Disclaimer: Curated by HT Syndication.
